Agentix Corp.
AGTX
Rank in Stocks
#32613
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Share Price
$0.0337
Last synced: 2026-11-10
Market Cap
$1.35M
Change (1 day)
0.00%
Change (1 year)
-24.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Agentix Corp. (AGTX)
Category
Healthcare
EPS for Agentix Corp. (AGTX)
EPS as of September 2026 TTM: $-0.01
According to Agentix Corp.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Agentix Corp. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -9.00% |
| 2025 | $-0.01 | -2.74% |
| 2024 | $-0.01 | -58.29% |
| 2023 | $-0.04 | -48.15% |
| 2022 | $-0.07 | -82.69% |
| 2021 | $-0.39 | 2,384.08% |
| 2020 | $-0.02 | -77.57% |
| 2019 | $-0.07 | -100.00% |
| 2018 | $-7.74K | 11,120.45% |
| 2017 | $-68.95 | 38.87% |
| 2016 | $-49.65 | 68.94% |
| 2015 | $-29.39 | -22.76% |
| 2014 | $-38.05 | 661.00% |
| 2013 | $-5.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -172,187.91% |
US
|
|
| $-7.07 | 77,592.31% |
US
|
|
| $-5.29 | 58,031.87% |
AU
|
|
| $12.88 | -141,639.56% |
BE
|
|
| $21.56 | -237,023.08% |
NL
|
Questions about Agentix Corp.'s earnings per share (EPS)
What is Agentix Corp.'s earnings per share (EPS)?
Agentix Corp.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Sep 2026.
What was Agentix Corp.'s earnings per share (EPS) in 2025?
In 2025, Agentix Corp.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Agentix Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Agentix Corp.'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2021 ($-0.39).
How does Agentix Corp.'s earnings per share (EPS) compare with similar companies?
Agentix Corp.'s earnings per share (EPS) ($-0.01) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.